Medac Disodium Pamidronate (pamidronate): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Medac Disodium Pamidronate 3 mg/ml, sterile concentrate

Medac Disodium Pamidronate 3 mg/ml is indicated for the treatment of conditions associated with increased osteoclast activity:

• Tumour-induced hypercalcaemia

• Osteolytic lesions in patients with bone metastases associated with breast cancer

• Multiple myeloma stage III


Molecule: pamidronate

Patients' opinions on Medac Disodium Pamidronate

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.

Conditions related to this medication

Fact sheet

Breast cancer

See the fact sheet